作者:
Tabor, David E. [1]
;
Yu, Li [2]
;
Mok, Hoyin [3]
;
Tkaczyk, Christine [4]
;
Sellman, Bret R. [5]
;
Wu, Yuling [6]
;
Oganesyan, Vaheh [7]
;
Slidel, Tim [8]
;
Jafri, Hasan [9]
;
McCarthy, Michael ;
Bradford, Patricia ;
Esser, Mark T.
作者单位:
MedImmune LLC, Stat Sci, Gaithersburg, MD USA
[1]
AstraZeneca, Global Med Dev, Waltham, MA USA
[2]
MedImmune LLC, Infect Dis Innovat Med, Gaithersburg, MD USA
[3]
MedImmune LLC, Appl Immunol & Microbiol, Mountain View, CA 94043 USA
[4]
MedImmune LLC, Infect Dis Vaccine Res, Gaithersburg, MD USA
[5]
MedImmune LLC, Infect Dis Clin Res, Gaithersburg, MD USA
[6]
MedImmune LLC, Res Bioinformat, Cambridge, England
[7]
MedImmune LLC, Antibody Discovery & Prot Engn, Gaithersburg, MD USA
[8]
MedImmune LLC, Clin Pharmacol & DMPK, Gaithersburg, MD USA
[9]
发布时间
2017-12-20